A nomogram for predicting the likelihood of additional nodal metastases in breast cancer patients with a positive sentinel node biopsy

被引:641
作者
Van Zee, KJ
Manasseh, DME
Bevilacqua, JLB
Boolbol, SK
Fey, JV
Tan, LK
Borgen, PI
Cody, HS
Kattan, MW
机构
[1] Mem Sloan Kettering Canc Ctr, Dept Surg, New York, NY 10021 USA
[2] Mem Sloan Kettering Canc Ctr, Dept Pathol, New York, NY 10021 USA
[3] Mem Sloan Kettering Canc Ctr, Dept Urol, New York, NY 10021 USA
[4] Mem Sloan Kettering Canc Ctr, Dept Epidemiol & Biostat, New York, NY 10021 USA
关键词
axillary metastases; breast cancer; nomogram; prediction; sentinel node;
D O I
10.1245/ASO.2003.03.015
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: The standard of care for breast cancer patients with sentinel lymph node (SLN) metastases includes complete axillary lymph node dissection (ALND). However, many question the need for complete ALND in every patient with detectable SLN metastases, particularly those perceived to have a low risk of non-SLN metastases. Accurate estimates of the likelihood of additional disease in the axilla could assist greatly in decision-making regarding further treatment. Methods: Pathological features of the primary tumor and SLN metastases of 702 patients who underwent complete ALND were assessed with multivariable logistic regression to predict the presence of additional disease in the non-SLNs of these patients. A nomogram was created using pathological size, tumor type and nuclear grade, lymphovascular invasion, multifocality, and estrogen-receptor status of the primary tumor; method of detection of SLN metastases; number of positive SLNs; and number of negative SLNs. The model was subsequently applied prospectively to 373 patients. Results: The nomogram for the retrospective population was accurate and discriminating, with an area under the receiver operating characteristic (ROC) curve of 0.76. When applied to the prospective group, the model accurately predicted likelihood of non-SLN disease (ROC, 0.77). Conclusions: We have developed a user-friendly nomogram that uses information commonly available to the surgeon to easily and. accurately calculate the likelihood of having additional, non-SLN metastases for an individual patient.
引用
收藏
页码:1140 / 1151
页数:12
相关论文
共 49 条
[11]   Clinical aspects of sentinel node biopsy [J].
Cody, HS .
BREAST CANCER RESEARCH, 2001, 3 (02) :104-108
[12]  
Czerniecki BJ, 1999, CANCER, V85, P1098, DOI 10.1002/(SICI)1097-0142(19990301)85:5<1098::AID-CNCR13>3.3.CO
[13]  
2-E
[14]  
Dowlatshahi K, 1997, CANCER, V80, P1188, DOI 10.1002/(SICI)1097-0142(19971001)80:7<1188::AID-CNCR2>3.0.CO
[15]  
2-H
[16]  
Gann PH, 1999, CANCER, V86, P1511, DOI 10.1002/(SICI)1097-0142(19991015)86:8<1511::AID-CNCR18>3.0.CO
[17]  
2-D
[18]   Prospective observational study of sentinel lymphadenectomy without further axillary dissection in patients with sentinel node-negative breast cancer [J].
Giuliano, AE ;
Haigh, PI ;
Brennan, MB ;
Hansen, NM ;
Kelley, MC ;
Ye, W ;
Glass, EC ;
Turner, RR .
JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (13) :2553-2559
[19]   Sentinel lymphadenectomy in breast cancer [J].
Giuliano, AE ;
Jones, RC ;
Brennan, M ;
Statman, R .
JOURNAL OF CLINICAL ONCOLOGY, 1997, 15 (06) :2345-2350
[20]   LYMPHATIC MAPPING AND SENTINEL LYMPHADENECTOMY FOR BREAST-CANCER [J].
GIULIANO, AE ;
KIRGAN, DM ;
GUENTHER, JM ;
MORTON, DL .
ANNALS OF SURGERY, 1994, 220 (03) :391-401